| 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Profit/loss | -1,2 M € | +91.6% | -14,4 M € | -323.0% | -3,4 M € | -276.6% | -903,4 k € | |
| Equity | 87,2 M € | -1.4% | 88,4 M € | -14.0% | 102,8 M € | -3.4% | 106,3 M € | |
| Gross margin | — | — | — | — | ||||
| Staff | 3,4 | 1,9 | 2,5 | 0,9 | ||||
Key indicators
| Unit no. | Name | Location |
|---|---|---|
| 2263927441 | Hyloris Pharmaceuticals | Boulevard de Patience et Beaujonc 3 box 1, 4000 Liège |
Public limited company · Liège · incorporated on 10/04/2017 · 3,4 ETP
Public limited company en perte sur le dernier exercice. Trésorerie en repli (-47.9 %).
Source: filing of 07/07/2026
7-day free trial, no credit card required.
Source: Belgian Official Gazette